produit
Glycostab
 |
It is possible to prevent the appearance of pathologies related to sugar management disorders, with a balanced diet, physical exercises combined with the use of GLYCOSTAB.
GLYCOSTAB may support regulation of pancreatic functions . |
contenu avec onglet
The Larousse Illustrated Dictionary defines diabetes as “Trouble in the metabolism of carbohydrates due to a lack of action of pancreatic insulin characterized by hyperglycemia and sometimes by the presence of sugar in the urine (glycosuria)." It is possible to prevent the appearance of pathologies related to the management of sugar disorders, through a balanced diet, physical exercises combined with the use of GLYCOSTAB.
GLYCOSTAB may support regulation of the pancreatic functions .
GLYCOSTAB may support regulation of the pancreatic functions .
Standardization
| Plant/Ingredient | Standardization |
Quantity of dried plant
per 7,5ml
|
| Garcinia | HCA 5 % | 600 mg (Bark, fruits) |
| Neem | Azadirachtine 0,2 % | 200 mg (Leaves) |
| Gymnema | Gymnémic acid 5 % | 150 mg (Leaves) |
| Bitter melon | Bitter principes 3 % | 150 mg (Whole) |
| Coffee | Chlorogenic acid 1% | 100 mg (Fruits) |
| Salad extract | Chlorogenic acid 9 % | 100 mg (Leaves) |
| Stevia | Steviosides 1 % | 20 mg (Leaves) |
| Banaba | Corosolic acid 1 % | 18 mg (Leaves) |
| Chromium (Chelated with aminoacids) | N/A | 24 mcg |
Pharmacological activity
The natual products and plants in this formulation are traditionnally used for the following effects:
GARCINIA (Garcinia Cambogia)
Origine : Asie
- Support weight loss and reduced appetite;
- Reduce the frequency and intensity of sugar rages.
MARGOUSIER (Azadirachta Indica)
Origin : India
- Helps to prevent diabetes and to reduce glucose level ;
- Hypotensor.
GYMNEMA (Gymnema Sylvestre)
Origin : India
- Contribute to droppingt of cholestérol and triglycerides levels in type I diabetecs ;
- Contribue to dropping blood glucose in diabetics and non insulino-dependants patients.
BITTER MELON (Mormodica Charantia)
Origin : IndIA
- Contribute to reduce the glucose level of diabetics.
COFFEE (extract)
Origin : South America
- Improve short-term vigilance ;
- Helps to prevent diatetes.
SALAD EXTRACT
- Helps to stabilize blod glucose;
- Use in the treatment of diabetes.
STEVIA (Stevia Rebaudiana)
Origin : South America
- Induce a drop in blood glucose level and lower blood pressure;
- Stimulate insulin production regulation.
BANABA (Lagerstroemia Speciosa)
Origine : Japon
- Help to regulate insulin and blood sugar rates;
- Used in the treatment of diabetes and hyperglycemia ;
- Help to control appetite.
CHROME
- Contribute to weight-loss and blood glucose management.
Glycostab may be used in several ways, in different occasions:
- Prolonged use: Take 1½ teaspoon (7,5 ml) daily.
- Hypoglycemia state: Take 1½ teaspoon (7,5 ml) twice a day, during lunch and supper.
- In case of overeating: After a very heavy meal or a meal rich in carbohydrates, a punctual dose of 1½ teaspoon may be added to the normal dosage.
When: Take while eating or immediately after a meal. Allow at least 2 hours before taking chrome, zinc, calcium carbonate or antacid supplements.
*Refrigerate after opening.
CONTRAINDICATIONS
- Interacts with insulin;
- Avoid in the event of serious pathologies;
- Avoid in the case of hypoglycemia;
- Cardiac and renal diseases;
- Gastric and duodenal ulcers.
Chromium has an amplifying effect in the treatment of diabetes. When a patient is on medication to treat his diabetes, give this product only with the agreement and the careful monitoring of his attending physician.
PRECAUTIONS
- Avoid giving to children under 12 years of age;
- Avoid giving in the case of a pregnancy or breastfeeding;
- Always consult with a health practitioner. Diabetes is a grave disease whose treatment requires obligatory strict medical monitoring. Self-treatment can cause very serious consequences;
- Presence of caffeine: certain people can feel symptoms of this formulation if taken in high proportions;
- Avoid taking another medication within two hours before or two hours after the dose of Glycostab;
- Cease the use and consult a health practitioner if the symptoms persist or if undesirable effects should occur.
MEDICINAL INTERACTION
- Increases analgesic effects like with acetaminophen and acetylsalicylic acid;
- Interacts with any medication used in the treatment of diabetes;
- Bronchodilators and theophylline;
- Ephedrine and amphetamine derivatives;
- Cimetidine, Clozapine;
- Verapamil;
- This product can modify, decrease or increase Alendronate effects, corticosteroid sedation and sedatives, calcium carbonate and antacids;
- In the event of serious disease or consumption with other medications, do not take this product without the consent of an expert healthcare professional.
UNDESIRABLE EFFECTS
Undesirable effects are very rare:- Nervousness, agitation, palpitations, breathing acceleration in the presence of caffeine;
- Gastric irritation;
- Muscle cramps, headaches, fatigue, dizzy spells, insomnia;
- Allergic reaction to plants of the asteracees family.
Glycostab is recommended to all those who present:
- Genetic predisposition to sugar rate imbalance;
- An abnormal high blood sugar level, without a definite diabetes diagnostic (or any other) having been established;
- Characteristic symptoms of hypoglycemia (lack of energy, concentration, etc);
- Overweight. A glycemia level stabilization, a better sugar management associated with exercises and a diet program will significantly accelerate weight loss.
* Diabetes is a serious illness and should always be followed by a doctor. This product does not replace any medical treatment.
- Hemmerle H. , Burger H.J., Herling A.W. and al, Chlorogenic acid and synthetic chlorogenic acid derivates : novel inhibitors of hepatic glucose- 6-phosphate translocase. J Med Chem. 1997; 40(2) : 137-145
- Herling, Andreas W., H J Burger, D Schwab, H Hemmerle, P Below and 2) G scubert. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am physiological society 0193-1857/98 G1087-G1093
- Delcy V.Rodriguez de Sotillo, M Hadley. Chlorogenic acid modifies plasma and liver concentrations of : cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J nutritional biochemistry; 13 (2002) 717-726 . http://www.plthomas.com/PLTbrands/xtrasalad.htm
- http://www.bioserae.com/nutraveggie-onion-salad-extract.php
- Murakami C, Myoga K, Kasai R, Ohtani K, Kurokawa T, Ishibashi S, Dayrit F, Padolina WG, Yamasaki K. Screening of plant constituents for effect on glucose transport activity in Ehrlich ascites tumour cells. Chem Pharm Bull (Tokyo). 1993 Dec ; 41(12): 2129-31.
- Ahn KS, Hahm MS, Park EJ, et al. Corosolic acid isolated from the fruit of Crataegus pinnatifida var. pilosa is a protein kinase inhibitor a well as a cytotoxic agent. Planta Med. 1998; 64:468-470.
- Kakuda T, Sakane I, Takhara T, et al. Hypoglycemic effect of extracts from Lagerstroemia speciosa L. leaves in genetically diabetic KK-AY mice. Biosci Biotechnol Biochem. 1996; 60:204-208.
- Kakuda T, Sakane I, Takihara T, Ozaki Y, Takeuchi H, Kuroyanagi M. Hypoglycemic effect of extracts from Lagerstroemia speciosa L. leaves in genetically diabetic KK-AY mice. Biosci Biotechnol Biochem. 1996 Feb; 60(2): 204-8.
- Blumenthal M (Ed). The Complete German Commission E Monographs, American Botanical Council, published om collaboration with Integrative Medicine Communications, United States, 1998.
- Therapeutic Research Faculty (Ed). Coffee, Natural Medicines Comprehensive Database. www.naturaldatabase.com
- Diabète Québec (http://www.diabete.qc.ca)
- Santé Canada. Feuille d'information sur la caféine et votre santé. Santé Canada, 2003. www.hc-sc.gc.ca/
- Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials.Am J Epidemiol. 2001 Feb 15;153(4): 353-62.
- Urgert R, Meyboom S, Kuilman M, Rexwinkel H, Vissers MN, Klerk M, Katan MB. Comparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial.BMJ. 1996 Nov 30;313(7069):1362-6.
- Ryan GJ, Wanko NS, Redman AR, Cook CB. Chromium as adjunctive treatment for type II diabetes. Ann Pharmacother. 2003 Jun;37(6):876-85. Review.
- Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr. 2000 Jul; 76(1): 148-55.
- Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003 Apr; 26(4): 1277-94.
- Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, Chowdhury S. Role of chromium supplementation in Indians with type II diabetes mellitus. J Nutr Biochem. 2002 Nov;13(11):690-697.
- Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type II diabetes. Diabetes. 1997;46(11):1786-1791.
- Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type II diabetes.Saudi Med J. 2000 Sep;21(9):831-7.
- McCarty MF. Utility of metformin as an adjunct to hydroxycitrate/carnitine for reducing body fat in diabetics. Med Hypotheses. 1998 Nov; 51(5): 399-403.
- The Natural Pharmacist (Ed). Natural Products Encyclopedia, Herbs & Supplements - Hydroxycitric Acid, ConsumerLab.com. www.consumerlab.com
- Therapeutic Research Faculty (Ed). Garcinia, Natural Medicines Comprehensive Database. www.naturaldatabase.com
- Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK. Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia.J Agric Food Chem. 2002 Jan 2;50(1):10-22.
- Van Loon LJ, van Rooijen JJ, Niesen B, Verhagen H, Saris WH, Wagenmakers AJ. Effects of acute (-)-hydroxycitrate supplementation on substrate metabolism at rest and during exercise in humans.Am J Clin Nutr. 2000 Dec;72(6):1445-50.
- Preuss HG, Bagchi D, Bagchi M, Rao CV, Dey DK, Satyanarayana S. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes Metab. 2004 May;6
- Jellin JM, Gregory P, Batz F, Hitchens K, et al. Natural Medicines Comprehensive Database. Therapeutic Research. Stockton, CA. Stevia. www.naturaldatabase.com
- McGuffin Michael (Dir.). Botanical Safety Handbook. CRC Press, Boca Raton, Floride, 1997.
- Duke J. Dr. Duke's Phytochemical and Ethnobotanical Databases : Ethnobotanical uses : Stevia rebaudiana. USDA, ARS, Genetic Resources Web Server. 1994. www.ars-grin.gov
- Curi R, Alvarez M, Bazotte RB, Botion LM, Godoy JL, Bracht A. Effect of Stevia rebaudiana on glucose tolerance in normal adult humans. Braz J Med Biol Res 1986;19(6):771-4
- Jeppesen PB, Gregersen S, Poulsen CR, Hermansen K. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity.Metabolism 2000 Feb;49(2):208-14
- Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes.Diabetes Care 2003 Apr;26(4):1277-94.
- Okabayashi Y, Tani S, Fujisawa T, Koide M, Hasegawa H, Nakamura T, Fujii M, Otsuki M. Effect of Gymnema sylvestre, R.Br. on glucose homeostasis in rats.Diabetes Res Clin Pract 1990 May-Jun;9(2):143-8.
- Shanmugasundaram ER, Rajeswari G, Baskaran K, Rajesh Kumar BR, Radha Shanmugasundaram K, Kizar Ahmath B. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus.J Ethnopharmacol 1990 Oct;30(3):281-94.
- Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients.J Ethnopharmacol 1990 Oct;30(3):295-300.
- Joffe DJ, Freed SH. Effect of extended release Gymnema sylvestre leaf extract alone or in combination with oral hypoglycemics or insulin regimens for type I1 and type II diabetes.
- Diabetes Control Newsl. 2001; 76(1): 1-4. Étude mentionnée dans: Bone K. Phytotherapy for Diabetes With a Focus on Gymnema. Integrative Medicine, Vol. 2, No 2, April/May 2003.
- Khosla P, Bhanwra S, Singh J, et al. A study of hypoglycaemic effects of Azadirachta indica (Neem) in normal and alloxan diabetic rabbits. Indian J Physiol Pharmacol. 2000;44:69-74.
- Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AH. Improvement in glucose tolerance due to Momordica charantia (karela).Br Med J (Clin Res Ed) 1981 Jun 6; 282(6279): 1823-4.
- Srivastava Y, Venkatakrishna-Bhatt H, Verma Y. Effect of Momordica charantia Linn. pomous aqueous extract on cataractogenesis in murrin alloxan diabetics.Pharmacol Res Commun 1988 Mar;20(3):201-9.
- Grover JK, Vats V, Rathi SS, Dawar R. Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice.J Ethnopharmacol 2001 Aug;76(3):233-8.
- Vikrant V, Grover JK, Tandon N, Rathi SS, Gupta N. Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats.J Ethnopharmacol 2001 Jul;76(2):139-43.
- Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.J Ethnopharmacol 1986 Sep;17(3):277-82.
- Matsuur H, Asakawa C, Kurimoto M, Mizutani J. Alpha-glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa.Biosci Biotechnol Biochem 2002 Jul;66(7):1576-8.
- Schmutterer, H. and K.R.S. Ascher, eds. 1987. Natural Pesticides from the Neem Tree A. Juss.) (Azadirachta indica and Other Tropical Plants.
- Ahmed, S., ed. In press. Neem (Azadirachta indica) for pest control and rural development in Asia and the Pacific. Special session on neem from the 17th Pacific Science Congress, May 27 to June 2, 1991.
- Joffe DJ, Freed SH. Effect of extended release Gymnema sylvestre leaf extract alone or in combination with oral hypoglycemics or insulin regimens for type I1 and type II diabetes. Diabetes Control Newsl. 2001; 76(1): 1-4.
Voici les combinaisons de produits suggérés aux individus souffrants des problèmes suivants :
- Les personnes exposées à un risque de prise de poids et qui sont à risque de diabète devraient combiner Glycostab avec Métabotonik, ce dernier aidera au contrôle de gain de poids. La relation du diabète de type II avec l'obésité est extrêmement forte, à tous les niveaux épidémiologique, physiopathologique et thérapeutique. Environ 80 % des patients diabétiques de type II ont un excès pondéral ou une obésité. Les études épidémiologiques ont montré qu'une prise de poids est significativement associée à un risque accru de développer un diabète de type II Inversement, des études d'intervention ont montré qu'un amaigrissement, même relativement modéré (quelques kilogrammes), suffit à réduire remarquablement le risque de progresser d'une diminution de la tolérance au glucose vers un diabète de type II ;
- La perte d'énergie étant un facteur lié au diabète, les personnes concernées devraient combiner le produit Blitz, qui aide à augmenter l'énergie générale avec Glycostab ;
- Les personnes atteintes du diabète doivent changer ou contrôler leur alimentation et doivent éviter de fumer. Les personnes en sevrage tabagique ou d'autres drogues devraient combiner Glycostab avec Relaximum. Ce produit aide à régulariser les symptômes reliés à l'accoutumance ou au " manque ". Souvent, en cessant de consommer une drogue, les symptômes d'anxiété, de fébrilité, de goût prononcé pour la substance éliminée se produisent. Relaximum aide aussi à atténuer ces effets désagréables du sevrage. Dépendamment des symptômes, le patient devrait utiliser aussi lors du premier mois, le produit Neurotonik, afin de réduire les risques de rechute et aider à rebalancer les neurotransmetteurs. Ce produit pourrait aussi être combiné à D-Toxi afin d'éliminer les résidus néfastes de la drogue et d'accélérer son évacuation du système. AntiOxy Bio est aussi suggéré, de même que Métabotonik si le patient compense ses symptômes en mangeant trop.
|
|
|
